Case of bullous pyoderma gangrenosum in a child

Authors

  • Nadia Ali Azfar Department of Dermatology Unit I, Allama Iqbal Medical College/ Jinnah Hospital, Lahore
  • Ummara Rafique
  • Rafia Hafeez Department of Dermatology Unit I, Allama Iqbal Medical College/ Jinnah Hospital, Lahore
  • Tariq Rashid Department of Dermatology Unit I, Allama Iqbal Medical College/ Jinnah Hospital, Lahore

DOI:

https://doi.org/10.66344/jpad.v27i3.1119

Keywords:

Bullous pyoderma gangrenosum, corticosteroids, Thalidomide

Abstract

Bullous pyoderma gangrenosum is an atypical variety of pyoderma gangrenosum characterized by rapidly evolving vesicles or bullae that later rupture to form ulcers, commonly associated with underlying hematological malignancy. Various therapeutic options are available, including corticosteroids and other immunosuppressive agents. We present an eight-year-old boy having recalcitrant bullous pyoderma gangrenosum treated successfully with thalidomide.

References

1. Bhat RM. Pyoderma gangrenosum:An update. Indian Dermatol Online J. 2012;3: 7-13

2. Wollina U. Pyoderma gangrenosum – a review. Orphanet J Rare Dis. 2007;2:19

3. Konopka CL, Padulla GA, Ortiz MP, Beck AK, Bittencourt MR, Dalcin DC. Pyoderma gangrenosum - A review article. J Vasc Bras. 2013;12:25-33.

4. Gettler S, Rothe M, Grin C, Grant-Kels J. Optimal treatment of pyoderma gangrenosum. Am J Clin Dermatol. 2003;4:597-608.

5. Wollina U. Clinical management of pyoderma gangrenosum. Am J Clin Dermatol. 2002;3:149-58.

6. Patel GK, Rhodes JR, Evans B, Holt PJA. Successful treatment of pyoderma gangrenosum with topical 0.5% nicotine cream. J Dermatol Treat. 2004;15:122-5.

7. Federman GL, Federman DG. Recalcitrant pyoderma gangrenosum treated with thalidomide. Mayo Clin Proc. 2000;75:842-4.

8. Daniels LH, Callen JP. Mycophenolate mofetil is an effective treatment for peristomal pyodermagangrenosum. Arch Dermatol. 2004;140:1427-9.

9. Tüzün Y, Maraşoğlu Ö. Pyoderma gangrenosum. J Turk Acad Dermatol. 2007;1 (3):ss71301r.

10. Peuckmann V, Fisch M, Bruera E. Potential novel uses of thalidomide. Drugs. 2000;60:273-92.

11. Malkan UY, Gunes G, Eliacik E, Haznedaroglu IC. Treatment of pyoderma gangrenosum with thalidomide in a myelodysplastic syndrome case. Int Med Case Rep J. 2016;9:61-4.

12. Wolska K, Michalska-Jakubus M, Pucuła J, Chodorowska G, Dzida G, Mosiewicz J. et al. Bullous pyoderma gangrenosum associated with pancytopenia of unknown origin. Postepy Dermatol Allergol. 2014;31:272-6.

13. Graham JA, Kathryn Kay Hansen KK, Rabinowitz LG, Esterly NB. Pyoderma Gangrenosum in infants and children: Pediatr Dermatol. 1994;11:10-7.

Downloads

Published

15.03.2018

Issue

Vol. 27 No. 3 (2017): July - September

Section

Case Reports

License

Copyright (c) 2018 Nadia Ali Azfar, Ummara Rafique, Rafia Hafeez, Tariq Rashid

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Submission declaration

Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.

By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.

How to Cite

1.
Case of bullous pyoderma gangrenosum in a child. J Pak Assoc Dermatol [Internet]. 2018 Mar. 15 [cited 2026 Aug. 2];27(3):286-9. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/1119